Head-to-head · free
Intuitive Surgical, Inc. vs Cyclerion Therapeutics
ISRG vs KRSA — return on capital, cash generation, margins and balance sheet side by side.
ISRG
4 / 4
measures where ISRG leads
KRSA
0 / 4
measures where KRSA leads
A simple count of which company scores better on each measure — not a recommendation to buy or sell.
| Measure | ISRG · FY2025 | KRSA · FY2025 |
|---|---|---|
| Revenue | $10.1B | $2.1M |
| Net income | $2.9B | (3.5M) |
| Revenue growth (yearly, multi-year) | 67.1% | -19.3% |
| Free cash flow | — | — |
| Free cash flow margin | — | — |
| Net cash / (debt) | — | — |
| ROIC | 14.8% | — |
| Return on equity | 16.7% | — |
| Gross margin | 66.0% | — |
| Operating margin | 29.3% | — |
| Net debt / EBITDA | -0.93x | 4.13x |
Figures are as reported by each company; latest fiscal year shown.
Where Intuitive Surgical, Inc.'s cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Where Cyclerion Therapeutics's cash went (FY2025)
- Capital spending
- —
- Buybacks
- —
- Dividends
- —
- Acquisitions
- —
- Net debt issued / (repaid)
- —
Ask which business is stronger
"Which one reinvests at higher returns?" "Who carries more risk in its filings?" Get answers drawn straight from both companies' filings.
Compare them free